Evolent Health (EVH) Cash from Investing Activities (2015 - 2026)

Evolent Health has reported Cash from Investing Activities for 12 years, with the latest figure at -$6.7 million in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 88.93% year-over-year to -$6.7 million in Q2 2026; TTM through Jun 2026 was $60.3 million, a 153.22% increase from a year earlier, with the FY2025 full-year figure at -$233000.0, up 99.63% from the prior year.
• Cash from Investing Activities was -$6.7 million for Q2 2026 at Evolent Health, down from -$6.4 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $82.2 million in Q4 2025, with the low at -$395.0 million in Q1 2023.
• Average Cash from Investing Activities over 5 years is -$41.7 million, with a median of -$9.2 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities plunged 14081.81% in 2022, then jumped 512.21% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$4.5 million in 2022, then sank by 35.82% to -$6.1 million in 2023, then sank by 229.31% to -$19.9 million in 2024, then surged by 512.21% to $82.2 million in 2025, then sank by 108.15% to -$6.7 million in 2026.
• The last three Cash from Investing Activities figures came in at -$6.7 million (Q2 2026), -$6.4 million (Q1 2026), and $82.2 million (Q4 2025), per Business Quant data.